A case of pemetrexed-induced acute lung injury in non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 3, 2010, Pages 401-402

  Kim, Hye Ok ^a   Lee, Sung Yong ^a   Shim, Jae Jeong ^a   Kang, Kyung Ho ^a   Shin, Bong Kyung ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHENAMINE; NAVELBINE; PEMETREXED; PREDNISOLONE;

ACID FAST BACTERIUM; ACUTE LUNG INJURY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENDOSCOPIC SURGERY; FEMALE; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS WALL; LUNG BIOPSY; LUNG INFILTRATE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PLEURA METASTASIS; PRIORITY JOURNAL; SILVER STAINING; SPUTUM CULTURE; THORACOSCOPY; THORAX RADIOGRAPHY;

EID: 77649323235     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181c5b198     Document Type: Article

References (5)

1. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-1597.
2. Muller NL, White DA, Jiang H, et al. Diagnosis and management of drug-associated interstitial lung disease. Br J Cancer 2004;91(suppl 2): S24-S30.
3. Limper AH. Chemotherapy-induced lung disease. Clin Chest Med 2004; 25:53-64.
4. Higenbottam T, Kuwano K, Nemery B, et al. Understanding the mechanisms of drug-associated interstitial lung disease. Br J Cancer 2004; 91(Suppl 2):S31-S37.
5. Sun JM, Lee KW, Kim JH, et al. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer. Jpn J Clin Oncol 2009;39:27-32.